| Primary |
| Schizophrenia |
52.0% |
| Schizoaffective Disorder |
13.4% |
| Schizophrenia, Paranoid Type |
9.3% |
| Bipolar Disorder |
5.7% |
| Constipation |
2.4% |
| Psychotic Disorder |
2.4% |
| Agitation |
1.6% |
| Affective Disorder |
1.2% |
| Bipolar I Disorder |
1.2% |
| Chest Pain |
1.2% |
| Dementia |
1.2% |
| Pain |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Schizophrenia, Undifferentiated Type |
1.2% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Dyspepsia |
0.8% |
| Haemorrhoids |
0.8% |
| Sinusitis |
0.8% |
| Sleep Disorder |
0.8% |
| Aggression |
0.4% |
|
| Hospitalisation |
38.5% |
| Death |
6.8% |
| Abnormal Behaviour |
4.7% |
| Sedation |
4.7% |
| Psychotic Disorder |
4.3% |
| Schizophrenia |
4.3% |
| Mental Disorder |
3.8% |
| Overdose |
3.8% |
| Injection Site Haemorrhage |
3.4% |
| Psychiatric Decompensation |
3.4% |
| Drug Dose Omission |
3.0% |
| Prescribed Overdose |
3.0% |
| Agitation |
2.6% |
| Aggression |
2.1% |
| Road Traffic Accident |
2.1% |
| Swollen Tongue |
2.1% |
| Weight Increased |
2.1% |
| Cardiac Disorder |
1.7% |
| Myocardial Infarction |
1.7% |
| Somnolence |
1.7% |
|
| Secondary |
| Schizophrenia |
49.1% |
| Schizophrenia, Paranoid Type |
19.6% |
| Schizoaffective Disorder |
7.1% |
| Bipolar Disorder |
5.4% |
| Schizoaffective Disorder Bipolar Type |
3.6% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Bipolar I Disorder |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Psychotic Disorder |
1.8% |
| Affective Disorder |
0.9% |
| Blood Cholesterol Increased |
0.9% |
| Convulsion |
0.9% |
| Depression |
0.9% |
| Drug Withdrawal Syndrome |
0.9% |
| Major Depression |
0.9% |
| Pain |
0.9% |
| Sleep Disorder |
0.9% |
| Thyroid Disorder |
0.9% |
|
| Somnolence |
11.7% |
| White Blood Cell Count Decreased |
10.0% |
| Prescribed Overdose |
8.3% |
| Hypoxia |
6.7% |
| Suicidal Ideation |
6.7% |
| Weight Increased |
6.7% |
| Hallucination |
5.0% |
| Psychotic Disorder |
5.0% |
| Schizophrenia |
5.0% |
| Cardiac Arrest |
3.3% |
| Delirium |
3.3% |
| Dizziness |
3.3% |
| Drug Effect Decreased |
3.3% |
| Hepatitis C |
3.3% |
| Hypertension |
3.3% |
| Overdose |
3.3% |
| Restlessness |
3.3% |
| Sedation |
3.3% |
| Thyroid Cancer |
3.3% |
| Agitation |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.0% |
| Schizophrenia, Paranoid Type |
40.0% |
| Schizophrenia |
20.0% |
|
| Psychiatric Decompensation |
33.3% |
| Psychotic Disorder |
33.3% |
| Somnolence |
33.3% |
|
